00:00Honourable Loizzo, therapeutic innovation, we are talking about it today at the Ministry in particular, therapeutic innovation for nasal polyposis and
00:08Severe asthma. What is the government's commitment?
00:11The institutions' commitment is to promote the entry into force of all these innovative long-acting drugs which, in addition to
00:21improving patient adherence to therapy substantially improves the patient's quality of life
00:29because doing a monthly or annual or quarterly administration certainly has a huge impact on the patient's quality of life and
00:40increases adherence to the clinical protocol with a higher percentage of patient recovery.
00:49Let's talk about longevity and healthy aging. How can we ensure these two issues for the population in the future?
00:58Today we must consider that by extending the average life of our patients we must, from an institutional point of view, create a
01:08skeletal network to support aging patients
01:13through active aging by promoting a more correct lifestyle but also a higher quality of medicines that
01:24they arrive at the bedside of our elderly patient
01:28in addition to a series of medical devices that can assist him in the pathological process remotely to make the treatments
01:38more available at home at the patient's home.